Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract

European Journal of Cancer Part A

Volumn 32, Issue 14, 1996, Pages 2506-2512

  Weidner, N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BLADDER CANCER; HUMAN; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; TUMOR GROWTH; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER;

EID: 0030484871     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00378-4     Document Type: Article

References (34)

1. 1. Weidner N, Folkman J. Tumor vascularity as a prognostic factor in cancer. In DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology, Philadelphia, J.B. Lippincott-Raven, 1996, 167-190.
2. 2. Wakui S, Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992, 168, 257-262.
3. 3. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl Med 1991, 324, 1-8.
4. 4. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent pronostic indicator in earlystage breast carcinoma. J Natl Cancer Inst 1992, 84, 1875-1887.
5. 5. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993, 143, 401-409.
6. 6. Fregene TA, Khanuji PS, Noto AC, et al. Tumor-associated angiogenesis in prostate cancer. Anticancer Res 1993, 13, 2377-2381.
7. 7. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostate carcinoma. Cancer 1994, 73, 678-687.
8. 8. Vesalainen S, Lipponen P, Talja M, Alhava E, Syrjanen K. Tumor vascularity and basement membrane structure as prognostic factors in T1-2M0 prostatic adenocarcinoma. Anticancer Res 1994, 14, 709-714.
9. 9. Hall MC, Troncoso P, Pollack A, et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with exernal beam radiotherapy. Urology 1994, 44, 869-875.
10. 10. Bostwick DG, Wheeler TM, Blute M, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996, 48, 57.
11. 11. Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer, submitted for publication.
12. 12. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinoma. Br J Urol 1994, 74, 762-766.
13. 13. Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 1995, 154, 59-71.
14. 14. Bochner BH, Cote RJ, Weidner N, et al. Tumor angiogenesis is an independent prognostic indicator of invasive transitional cell carcinoma of the bladder. J Natl Cancer Inst 1995, 87, 1603-1612.
15. 15. Grossfeld GD, Ginsberg DA, Stein JP, et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst, in press.
16. 16. Yoshino S, Dato M, Okado K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 1995, 2, 156-160.
17. 17. Nunus DM, Schmitz-Drager BJ, Motzer RJ, et al. Expression of basic fibroblast growth factor in primary renal tumors: correlation with poor survival. J Natl Cancer Inst 1993, 85, 1597-1599.
18. 18. Duensing S, Grosse J, Atzpodien J. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastasis in advanced renal cell carcinoma patients. Anticancer Res 1995, 15, 2331-2333.
19. 19. Nguyen M, Watanabe II, Budson AE. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994, 86, 356-361.
20. 20. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993, 143, 1255-1262.
21. 21. MacLennan GT, Bostwick DG. Microvessel density in renal cell carcinoma: lack of of prognostic significance. Urology 1995, 46, 27-30.
22. 22. Olivarez D, Ulbright T, DeRiese W, et al. Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res 1994, 54, 2800-2802.
23. 23. Smith-McCune KK, Weidner N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994, 54, 800-804.
24. 24. Guidi AJ, Abu-Jawdeh G, Berse B, et al. Vascular permeability factor (vasclar endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995, 87, 1237-1245.
25. 25. Wiggins DL, Granai CO, Steinhoff MM, Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995, 56, 353-356.
26. 26. Kainz C, Speiser P, Wanner C, et al. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res 1995, 15, 1549-1551.
27. 27. Kohno Y, Iwanari O, Kitao M. Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer 1993, 72, 2394-2400.
28. 28. Bremer GL, Tiebosch ATMG, van der Putten HWHM, Schouten HJA, de Haan J, Arends J-W. Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol 1996, 174, 126-131.
29. 29. Schlenger K, Hockel M, Mitze M, et al. Tumor vascularity - a novel prognostic factor in advanced cervical carcinoma. Gynecol Oncol 1995, 59, 57-66.
30. 30. Rutgers JL, Mattox TF, Vargas MP. Angiogenesis in uterine cervical squamous cell carcinoma. Int J Gynecol Pathol 1995, 14, 114-118.
31. 31. Abulafia O, Triest WE, Sherer DM, Hansen CC, Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol 1995, 86, 479-485.
32. 32. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995, 147, 33-41.
33. 33. Gasparini G, Bonoldi E, Viale G, et al. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer 1996, 69, 205-211.
34. 34. van Diests PJ, Zevering JP, Zevering LC, Baak JPA. Prognostic value of microvessel quantitation in cisplatin treated Figo 3 and 4 ovarian cancer patients. Path Res Pract 1995, 191, 25-30.